These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22460964)

  • 41. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
    Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
    Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
    Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
    BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
    Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
    AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.
    Harcourt G; Gomperts E; Donfield S; Klenerman P
    Gut; 2006 Oct; 55(10):1484-7. PubMed ID: 16543291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
    Girón-Ortega JA; Márquez-Coello M; Gutiérrez-Saborido D; Arizcorreta A; Cuesta-Sancho S; Girón-González JA
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1863-1871. PubMed ID: 33822285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological status does not influence hepatitis c virus or liver fibrosis in HIV-hepatitis C virus-coinfected patients.
    Collazos J; Cartón JA; Asensi V
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):383-9. PubMed ID: 20977357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of Liver Disease, AIDS, and Mortality Based on Discordant Absolute and Relative Peripheral CD4 T Lymphocytes in HIV/Hepatitis C Virus-Coinfected Individuals.
    Hansen S; Kronborg G; Benfield T
    AIDS Res Hum Retroviruses; 2018 Oct; ():. PubMed ID: 30205696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
    Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
    HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
    Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
    Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR.
    Saracino A; Bruno G; Scudeller L; Ladisa N; de Gennaro N; Allegrini M; Monno L; Angarano G
    J Clin Virol; 2016 Aug; 81():94-9. PubMed ID: 27371888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
    Nicolás D; Esteve A; Cuadros A; Campbell CNJ; Tural C; Podzamczer D; Murillas J; Homar F; Segura F; Force L; Vilaró J; Masabeu À; Garcia I; Mercadal J; Montoliu A; Ferrer E; Riera M; Cifuentes C; Ambrosioni J; Navarro G; Manzardo C; Clotet B; Gatell JM; Casabona J; Miró JM; ; Murillas J; Manzardo C; Masabeu A; Mercadal J; Cifuentes C; Dalmau D; Domingo P; Falcó V; Curran A; Agustí C; Montoliu A; Pérez I; Curto J; Gargoulas F; Gómez A; Rubia JC; Zamora L; Blanco JL; Garcia-Alcaide F; Martínez E; Mallolas J; Llibre JM; Sirera G; Romeu J; Jou A; Negredo E; Saumoy M; Imaz A; Bolao F; Cabellos C; Peña C; DiYacovo S; Van Den Eynde E; Sala M; Cervantes M; Amengual MJ; Navarro M; Segura V; Barrufet P; Molina J; Alvaro M; Payeras T; Gracia Mateo M; Fernández J
    Clin Infect Dis; 2016 Jun; 62(12):1578-1585. PubMed ID: 27126346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    Aibibula W; Cox J; Hamelin AM; Moodie E; Naimi AI; McLinden T; Klein MB; Brassard P
    HIV Med; 2018 Feb; 19(2):123-131. PubMed ID: 29094807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM
    PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    Kuniholm MH; OʼBrien TR; Prokunina-Olsson L; Augenbraun M; Plankey M; Karim R; Sarkar M; French AL; Pierce C; Strickler HD; Anastos K
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):162-70. PubMed ID: 27183178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    Oliver NT; Hartman CM; Kramer JR; Chiao EY
    AIDS; 2016 Oct; 30(16):2469-2476. PubMed ID: 27753678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.
    Sajadi MM; Pulijala R; Redfield RR; Talwani R
    AIDS; 2012 Sep; 26(15):1879-84. PubMed ID: 22824629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons.
    Blatt SP; Lucey CR; Butzin CA; Hendrix CW; Lucey DR
    JAMA; 1993 Feb; 269(5):622-6. PubMed ID: 8093628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.